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Purpose of review  
This review focuses on the recent technological advances in quantitative sodium (23Na) MRI to provide a non-
invasive measure of tissue viability for use in clinical studies of patients with kidney disease. 23Na MRI is the only 
non-invasive imaging technique that allows for the absolute spatial quantification of tissue sodium concentration 
(TSC), providing assessment of the corticomedullary sodium gradient (CMSG) in the kidney, and allowing 
measures of TSC in the skin and muscle. 
Recent findings 
23Na MRI of the kidney has demonstrated the sensitivity to measure the CMSG, providing the normal range in 
healthy subjects and demonstrating a reduction in CMSG in kidney disease and transplanted kidneys. Studies 
using 23Na and 1H MRI have shown that in humans skeletal muscle and skin can store sodium without water 
retention, and that sodium concentrations in muscle and skin increase with advancing age. Recent studies have 
shown that TSC can be mobilised during haemodialysis, and that skin sodium content links closely to left 
ventricular mass in patients with Chronic Kidney Disease.  
Summary 
23Na MRI is currently a research technique, but with future advances, 23Na MRI has potential to become a non-
invasive renal biomarker to measure tissue sodium storage for clinical studies.  
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Introduction 
Hydrogen (1H) based magnetic resonance imaging (MRI) and spectroscopy (MRS) is widely used to provide 
invaluable information on structure and function of the human body, but importantly other naturally abundant 
nuclei in biological tissue, such as sodium (23Na), can also be imaged. 23Na is the second most abundant NMR 
sensitive nucleus in the human body. 23Na imaging has the potential to provide complementary quantitative 
measures compared to 1H MR, however its use has been limited due to the far lower sensitivity of 23Na MRI in the 
body. Despite the demonstration of sodium MRI in the early 1980s (1, 2), it has only been in recent years that its 
use has been rediscovered, with the availability of high and ultra-high field (3 and 7 Tesla) MR scanners and 
advances in MR technology in terms of radiofrequency (RF) coil and pulse sequence design. Applications of 23Na 
MRI have been shown in the brain, heart, and cartilage, as well as the skin, muscle, and kidney which will be the 
focus of this review.  
 
Technical Aspects of Sodium MRI 
In vivo 23Na MRI is challenging compared to 1H MRI, due to its low sensitivity which is of the order of 3,000-20,000 
times less than 1H MRI (organ dependent). This results from the lower gyromagnetic ratio () of 23Na compared 
to 1H ( of 23Na is 11.26 MHz/T compared to 42.58 MHz/T), the quantum mechanical property of spin of the 23Na 
nucleus taking a value of (3/2) compared to (1/2) for 1H, and the low natural abundance of 23Na in the biological 
tissues. Further, the (3/2) spin results in sodium having a quadrupolar moment, meaning that the MR signal from 
sodium decays significantly faster than for protons, resulting in a short longitudinal (T1) and rapid bi-exponential 
transverse (T2) signal decay with fast (T2f, 60 % of signal) and slow (T2s, 40% of signal) components. 
 For implementation of 23Na MRI, the MR scanner needs to be equipped with specialised transmit and receive RF 
coils tuned to the resonance frequency of sodium nuclei at the respective field strength, but this is now possible 
on most MR scanners used for research purposes. In addition scanning hardware and pulse sequences need to 
image faster for 23Na MRI compared to 1H MRI, due to the rapid decay of the 23Na signal. To overcome the low 
sensitivity of 23Na MRI, signal-to-noise ratio (SNR) is gained by imaging at lower spatial resolution and signal 
averaging for a number of minutes compared to seconds typically used for 1H MRI. The linear proportionality of 
the 23Na NMR signal to the spin density then allows for the absolute quantification of the tissue sodium 
concentration on the basis of a known concentration reference phantom placed within the scanner. 
There have been a number of recent comprehensive reviews of sodium imaging (3-6) which describe the 
challenges of 23Na MR, advances in scanning hardware and imaging techniques, and provide an overview of 
applications of 23Na MRI. This review focuses on the potential role of 23Na MRI in nephrology, including imaging 
of the kidneys and the use of sodium MRI to study sodium stored in the muscle and in the skin, suggested to be 
of relevance in hypertension and chronic kidney disease.   
 
Biological Processes Assessable by Sodium MRI  
Sodium is a vital electrolyte in the body and plays several roles including maintaining the volume of blood and 
fluid and regulating pH within the body. At a cellular level, the concentration of sodium within and outside cells is 
carefully maintained by the sodium-potassium Na+/K+-ATPase pump, with a large difference in concentration 
between intracellular (10–15 mM) and extracellular sodium (140–150 mM). This produces a substantial 
electrochemical gradient, essential for transmitting nerve pulses and pumping ions through cells. This gradient is 
very sensitive to cell health and changes in this sodium gradient will be reflected in cell integrity. Typically, an 
increase of TSC indicates a loss of tissue viability and is associated with an increase of intracellular sodium due to 
the loss of integrity of the cell, and also with an increase of extracellular volume when cells are dying. Thus 23Na 
MRI could provide direct biochemical markers for cell integrity and tissue viability, or for following changes in 
tissue viability upon treatment. 
One of the main tasks of the human kidneys is to maintain the homeostasis of the body’s fluid and electrolyte 
balance by filtration of the plasma and excretion of the end products. The regulation of extracellular sodium and 
water balance in the kidney is of particular importance, as this leads to an increasing sodium concentration 
gradient from the renal cortex to the medulla. A high sodium concentration in the medulla is a crucial for the final 
concentration of the urine by reabsorption of water. The ability to image the TSC and monitor any changes in the 
corticomedullary sodium concentration gradient (CMSG) in vivo will potentially increase our knowledge of renal 
physiology and allow the monitoring of changes during a variety of kidney diseases.  
Recent evidence showing that sodium is stored in the skin and that interstitial electrolyte balance is achieved by 
renal and extra-renal mechanisms has identified a need for 23Na MRI to assess skin interstitial sodium in vivo under 
a variety of experimental conditions to evaluate the role of skin sodium in the pathogenesis of hypertension and 
cardiovascular disease (7).  Studies to date indicate these tissue sodium levels are not reliably measured by 
sampling blood or interstitial fluid. Recent evidence from chemical analysis of tissue electrolyte and water 
composition has shown that body sodium content does not always readily equilibrate with water, and cannot be 
exclusively controlled by the renal mechanisms. (8). In muscle, sodium changes have been linked to several 
disease states, including diabetes mellitus, hypertension, and cardiovascular risk. It has therefore been suggested 
that the pathophysiological process of skin and muscle sodium storage is of relevance for health and disease, with 
sodium accumulation in the extracellular space closely associated with essential hypertension (9).  
 
Sodium MRI of the kidney: normal range in healthy subjects and changes in kidney disease 
Sodium MRI of the kidney was first performed in 1988 at 1.5 Tesla (10), yielding low resolution sodium images.  It 
wasn’t until 2006, as MR hardware and imaging techniques developed, that sodium imaging of the kidney was 
performed at 3 Tesla (11), producing the first maps of sodium distribution in the kidney and a qualitative measure 
of the CMSG.  
Normal range in healthy subjects  
Quantitative measurement of the sodium concentration in the kidney was first achieved by Haneder et al. in 2011 
(12), using reference NaCl solutions of known concentration positioned alongside the patient for calibration of 
the kidney sodium images. Using this method, the effect of water loading on kidney 23Na concentration was 
measured in healthy volunteers, subjects abstained from water intake for six hours prior to their first 23Na MRI 
and subsequently ingested 1 litre of water 30 minutes prior to their second 23Na MRI. Water loading caused a 
reduction in the sodium concentration within the kidney, with a decrease from 63.5±9.3 mmol/L to 48.6±5.3 
mmol/L in the cortex and 108.0±10.9 mmol/L to 81.9±10.1 mmol/L in the medulla, but the corticomedullary 
sodium concentration gradient was not affected. They then advanced these 23Na MRI measures by assessing the 
corticomedullary gradient (13) using an higher spatial resolution isotropic voxels and investigated the use of the 
cerebrospinal fluid (CSF) 23Na signal as an internal reference.  In 2014,  Haneder et al. evaluated the feasibility of 
in vivo 23Na MRI of the corticomedullary gradient and measurement of 23Na transverse relaxation times (T2*) in 
human kidneys at ultra-high field (7 Tesla) (14), showing mean corticomedullary  23Na signal-to-noise ratio (SNR) 
increased from the cortex (32.2+/-5.6) towards the medullary pyramids (85.7+/-16.0) and 23Na T2* relaxation 
times differed statistically significantly (P < 0.001) between the cortex (17.9+/-0.8 ms) and medulla (20.6+/-1.0 
ms).  
Further studies were performed (15) to ascertain the normal range of corticomedullary sodium concentration in 
the healthy human kidney, with a mean sodium concentration in the cortex of 58±17 mmol/L (range 27-63 
mmol/L) and 99±18 mmol/L (range 126-187 mmol/L) in the medulla. No significant correlation was found 
between the sodium concentration and age, gender, BMI or glomerular filtration rate (GFR).  
 
Changes in Kidney Disease 
Haneder et al. performed two studies investigating the feasibility of using 23Na MRI to measure changes in the 
sodium concentration in the kidney in disease. In the first study, they combined 23Na MRI and functional 1H MRI 
to measure damage in the kidney exposed to radiotherapy to treat gastric cancer (16), as reviewed by (5) and 
shown in Figure 1. Functional 1H MRI revealed changes consistent with reduced cell density and tissue 
oxygenation and  23Na MRI showed a partial loss of sodium corticomedullary concentration gradient in the upper 
pole of the kidneys exposed to radiation, confirming that loss of CMSG may be an early marker of kidney damage. 
They further demonstrated the ability of 23Na MRI to detect changes in renal sodium content in vivo in a study of 
patients with central diabetes insipidus (17) by showing that both cortical and medullary sodium concentration 
decreased by a mean of 17.1±1.1%  following intranasal administration of 20μg desmopressin.  
In 2014, Moon et al. (18) performed 23Na MRI of transplanted kidneys using a dual tuned coil capable of aquiring 
both proton and sodium images within the same scan session without the need to reposition the patient. This 
allowed 1H and 23Na images to be overlaid, providing the advantage of accurate segmentation of the medulla and 
cortex based on the high quality 1H MRI images that could be applied to the corresponding 23Na image. A 
significant reduction was seen in the sodium concentration in the transplanted kidneys, 153.5±11.9 mM 
compared to the healthy controls, 192.2 ± 9.2 mM, and a reduction in the CMSG at 8.9 ± 1.5 mM/mm in the 
transplanted kidney and 10.5 ± 0.9 mM/mm in the healthy kidneys. However, there was no significant difference 
in sodium levels or CMSG between those transplanted kidneys with acute rejection versus normal function, 
though the sample size was small with only six patients. 
Sodium imaging of the kidneys was also performed by Budjan et al. (19) to assess the effect of renal denervation 
therapy in patients with therapy resistant hypertension. In the two patients studied no changes were found in 
renal TSC or CMSG at 1, 30 and 90 days following treatment.  
 
Sodium MRI of the skin and muscle: Normal range in healthy subjects; Effects of haemodialysis, and changes in 
Hypertension, Chronic Kidney Disease, and Acute Kidney Injury  
Recent findings using 23Na and 1H MRI have shown that muscle and skin can store sodium without water retention 
(20), contrary to previous opinion that an increase in sodium intake increases tissue water content. Muscle 23Na 
MRI is typically performed using a dedicated knee coil to provide sodium images of the calf muscle, whilst 
assessment of skin sodium requires higher spatial resolution imaging. To achieve this, skin 23Na MRI is typically 
performed on the calf muscle using customized RF surface coils to provide an in-plane spatial resolution of below 
1 mm.  Tubes of NaCl (10, 20, 30, and 40 mmol/L) are used as calibration standards to linearly relate the 23Na 
intensity to 23Na concentration. Typically a 1H image is also collected to measure water content. 
 
Normal range in healthy subjects  
In 2013, Kopp et al. (9) demonstrated the important finding that sodium concentrations can be quantified 
noninvasively in skin and skeletal muscle in humans with 23Na MRI, and that when coupled with conventional 1H 
MRI imaging, water content can be judged simultaneously. They observed an increase in sodium storage with 
advancing age, especially remarkable because salt-sensitivity in humans increases with age. Muscle sodium 
increase was less profound in women compared with men, and muscle sodium deposition was not accompanied 
by simultaneous water accumulation.  In contrast to muscle, increasing sodium content in the skin was paralleled 
with increasing skin water content. Wang et al. (21) recently investigated gender differences in the patterns of 
TSC in muscle and skin of the calf muscle using 23Na MRI and showed that sodium content appears to be higher 
in skin than in muscle for men, however women tend to have higher muscle sodium than skin sodium.  Linz et al. 
investigated the feasibility of high in-plane spatial resolution 23Na MRI in skin at 7 Tesla, demonstrating the 
benefits of 7 Tesla to assess sodium stores compared to 3 Tesla (22). 
 
Effects of Haemodialysis 
Sodium MRI has been used to study the removal of sodium from the skin and muscle during haemodialysis (HD) 
(23), collecting 23Na images of the calf before and after dialysis treatment. Skin and muscle sodium concentration 
increased with age in the HD patients, and also control subjects. Younger HD patients (<60 yrs) had similar skin 
and muscle sodium concentration as healthy controls before HD, after HD the sodium levels in muscle decreased 
(P<0.01) and also tended to decrease in skin (P=0.1). Older HD patients (≥60 yrs) initially had a higher TSC than 
controls, whilst post-dialysis a reduction in TSC was found such that the sodium concentration post-haemodialysis 
was similar to controls in both skin (P = 0.37) and muscle (P = 0.62). In addition, this study compared the skin and 
muscle 23Na MRI measures to the sodium eliminated by the dialyser, however no correlation was found between 
sodium removal from plasma and skin or muscle sodium reduction measured by MRI. This study therefore showed 
that tissue stores of sodium can be mobilised during HD but that secondary clearance of sodium from tissues is 
less predictable than clearance from the plasma.  
Further evidence of potential adverse effects of tissue sodium accumulation was provided by a study by Deger at 
al. (24), which used 23Na MRI to assess the mechanisms by which insulin resistance occurs in patients on 
maintenance haemodialysis compared to controls. All subjects underwent hyperinsulinemic-euglycemic-
euaminoacidemic clamp studies to measure disposal rates of glucose (GDR) and leucine (LDR) as well as 23Na MRI 
of the calf to assess the skin and muscle sodium concentration. GDR and LDR levels were lower in HD patients 
compared to healthy controls, whereas the muscle sodium concentration was higher in HD patients. An inverse 
linear relationship was found between TSC in the muscle and GDR and LDR in HD patients, a trend not found in 
the healthy controls. There were no significant differences in skin sodium between dialysis patients and controls. 
This study hence concluded that excessive muscle sodium may contribute to the development of insulin resistance 
in patients with end stage renal disease on haemodialysis.  
 
Changes in Hypertension 
It has long been recognised that high dietary sodium intake provokes hypertension in salt sensitive individuals but 
23Na MRI has made it possible to study the role of tissue sodium storage in this complex pathophysiology. Kopp 
et al. (9) found that sodium storage in skin of the upper calf increased with age in hypertensive patients as well 
as controls. Sodium concentration in muscle increased with age in men but not women. When corrected for age 
it was found that women with refractory hypertension had increased stored sodium in the skin, and men with 
refractory hypertension had increased sodium in muscle, compared with age-matched normotensive controls. 
Interestingly spironolactone treatment (in addition to another diuretic) in men with refractory hypertension was 
associated with lower muscle sodium concentration and a trend towards lower blood pressure (135±16 versus 
147±19 mm Hg; P=0.16) than men with refractory hypertension not receiving spironolactone. Further work is 
required to replicate these complex findings and elucidate the underlying mechanisms. 
 
Changes in Chronic Kidney Disease 
Chronic kidney disease (CKD) results in sodium retention and is linked with an increased risk of cardiovascular 
events, in part due to the high prevalence of left ventricular hypertrophy (LVH) in CKD.  The pathogenesis of LVH 
in CKD is not fully understood and associations with dietary sodium intake have been inconsistent.  A recent study 
found that in patients with CKD, high skin sodium content was associated with greater age, male sex, higher body 
mass index, higher 24 hour systolic blood pressure and number of antihypertensives, urine albumin excretion, 
diabetes and cardiovascular disease. Furthermore, skin sodium content in the calf correlated significantly with 
left ventricular mass (LVM) assessed with 1H cardiac MRI (r = 0.56, P < 0.001) (25). In multivariable linear 
regression analysis skin sodium content was a strong determinant of LVM, independent of 24 hour systolic blood 
pressure and total body hydration. 
 
Changes in Acute Kidney Injury 
Acute kidney injury (AKI) is frequently associated with accumulation of extracellular sodium and water but is has 
not previously been possible to quantitate this accurately. In recent work, Hammon et al. (26) assessed skin and 
muscle 23Na MRI in in seven patients with AKI, peripheral oedema and weight gain. Before dialysis patients with 
AKI evidenced higher calf muscle and skin sodium concentration than age matched controls, Figure 2. However, 
there was no reduction in skin and muscle sodium or water content after four to five cycles of haemodialysis 
despite this achieving a mean total ultrafiltration volume of 8.36 litres. These observations are in contrast to those 
in patients receiving chronic hemodialysis and others with heart failure. Limitations of this study include the small 
number of participants and variation in the haemodialysis delivered. The failure to reduce tissue sodium with 
acute haemodialysis in the setting of AKI may be due to more severe sodium accumulation in this setting and the 
unstable condition of patients leading to inconsistent sodium accumulation and mobilisation. The importance of 
this study is that it demonstrates the feasibility of monitoring tissue sodium with 23Na MRI in the context of AKI. 
Larger more detailed studies with standardised dialysis interventions are required to explore this topic further. 
 
Conclusion  
23Na MRI is a powerful technique providing the potential to image sodium distribution in the kidney, and visualize 
and monitor changes in the CMSG, a marker of the regulation of extracellular sodium concentration. 23Na MRI 
can also perform assessment of skin and muscle sodium concentration, and demonstrates changes with age and 
hypertension. However, currently 23Na MRI is a research technique only, requiring expensive hardware and 
software, which are not routinely available on clinical MR systems, preventing routine clinical application.  In 
future, important advances will be made by the fusion of 23Na images with the 1H morphological and functional 
images, such as perfusion and diffusion, to produce co-located complementary information. With further 
development 23Na MRI has potential to become a non-invasive renal biomarker of tissue viability and measure of 
tissue sodium storage for clinical studies.  
 
Key points 
 23Na MRI is the only non-invasive imaging technique that allows the absolute spatial quantification of 
tissue sodium concentration (TSC). 
 23Na MRI of the kidney has the sensitivity to measure the corticomedullary sodium gradient (CMSG), 
demonstrating a reduction in the CMSG in kidney disease and transplanted kidneys.  
 23Na MRI has demonstrated an increase in skin and muscle sodium storage with advancing age, and 
increased tissue sodium content in hypertensive patients. 
 23Na MRI is currently a research technique, but with future advances, 23Na MRI has potential to become 
a non-invasive renal biomarker and measure of tissue sodium storage for clinical studies. 
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Figures 
Figure 1.  A 56‐year‐old patient after adrenal stereotactic body radiotherapy. As an early effect of radiation 
therapy, the cortico‐medullary sodium gradient and sodium concentration are decreased in the left kidney. Left: 
color‐coded sodium concentration (mmol/L). Right: T2‐weighted morphological sequences. Middle: fusion of 23Na 
and morphological sequences. Top row: coronal orientation. Bottom row: axial orientation. Previously published.  
Zollner FG, Konstandin S, Lommen J, Budjan J, Schoenberg SO, Schad LR, et al. Quantitative sodium MRI of kidney. 
NMR in biomedicine. 2016 Feb;29(2):197-205. PubMed PMID: 25728879. Epub 2015/03/03. eng. 
 
Figure 2.  (Upper row) 23Na scans (gradient echo 23Na sequence) of a 61-year-old patient before and after acute 
hemodialysis therapy. The amount of Na+ in the skin, as well as in the skeletal muscle, did not significantly change. 
At the far right is a healthy person with little sodium in the skin and muscle. Four tubes containing aqueous 
solutions with increasing Na+ concentrations (10, 20, 30, and 40 mmol/L NaCl) were positioned inside the coil just 
below the patient's lower leg. Grayscale measurements of the tubes served as calibration standards for Na+ 
magnetic resonance imaging (23Na-MRI) of the skeletal muscle and the skin by relating intensity to a content in 
a linear trend analysis. (Lower row) The same patient before and after acute hemodialysis and the control subject 
viewed with conventional (1H) MRI (fat-suppressed inversion recovery [IR] sequence). The salt solutions appear 
white because of their water content.  Previously published.  Hammon M, Grossmann S, Linz P, Seuss H, Hammon 
R, Rosenhauer D, et al. 3 Tesla 23Na Magnetic Resonance Imaging During Acute Kidney Injury. Academic radiology. 
2017 Sep;24(9):1086-93. PubMed PMID: 28495210. Epub 2017/05/13. eng. 
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